Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
about
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancerVitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolismHeparin for assisted reproductionUnfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patientsLow molecular weight heparin for prevention of microvascular occlusion in digital replantationLow molecular weight heparin for prevention of microvascular occlusion in digital replantationAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerHeparin for assisted reproductionAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerLow molecular weight heparins versus unfractionated heparin for acute coronary syndromesVenous thromboembolic diseaseVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesHeparin induced thrombocytopenia: diagnosis and management updateLow-molecular-weight heparins in the treatment of venous thromboembolismRates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar.Arterial indications for the low molecular weight heparinsHeparin-induced thrombocytopenia: an updateHeparin-induced thrombocytopenia in solid organ transplant recipients: The current scientific knowledgeBudd-Chiari syndromeNeuraxial and peripheral nerve blocks in patients taking anticoagulant or thromboprophylactic drugs: challenges and solutionsHeparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrumsHITlights: a career perspective on heparin-induced thrombocytopeniaA systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiencyUse and safety of unfractionated heparin for anticoagulation during maintenance hemodialysisTravellers' thrombosis and economy class syndrome: incidence, aetiology and preventionAn update on prevention of venous thromboembolism in hospitalized acutely ill medical patientsCoagulation abnormalities in critically ill patientsEnoxaparin in acute coronary syndromesHeparin-induced thrombocytopenia-thrombosis syndrome and bilateral adrenal haemorrhage after prophylactic heparin useHeparin-induced thrombosisCerebral venous thrombosis due to cryptogenic organising pneumopathy with antiphospholipid syndrome worsened by heparin-induced thrombocytopenia.Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.Recent advances in epidural analgesia.Acute coronary syndromes: diagnosis and management, part IMonocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.Inferior vena cava thrombectomy in a patient with heparin-induced thrombocytopenia via inflow occlusion technique on beating heart.In vitro and in vivo characterization of a reversible synthetic heparin analog.Treatment of heparin-induced thrombocytopenia.
P2860
Q24193871-956F23D9-EBE0-46FB-A9EC-61A38C05681FQ24198032-E659CA65-8D19-4E66-BFB7-70969F00A44DQ24200403-7B30033C-32DA-41A5-B1C7-8E8744DABA9EQ24200589-DD182492-6AFE-47C1-9F44-91C3313C18FDQ24201302-03488321-2E51-46F1-8B85-1142023C155AQ24202982-1F75CFA2-A4EA-4BFA-9A4A-E524DFC805D2Q24234155-2030FE06-E0E8-44B5-8316-4BA4D8356090Q24235193-0D8DBAB5-1FA3-4EEC-9455-5D7358EC7B20Q24235499-12EE3233-38A0-405E-99EA-C559327DBD31Q24236443-7828D667-E756-4DD7-95B2-4334EE25B214Q24242243-0F1AE581-7F69-44CF-B1FE-A38CC15F7BA2Q24250287-7725B315-B102-45FF-833B-4277430D3933Q24631121-25CCE0D3-F6AE-4026-9784-5536AE3A8F04Q24632982-E6342E66-3D8D-4B05-99EA-E7DB21D633D3Q24647207-71D92A4E-EC58-481E-A60A-B735837893EAQ24792692-86261A07-EF70-4CFD-ADAA-5D18AA5DF282Q24795717-0CC5A977-BCE3-468D-9C05-81E5C195EC4FQ24806932-339EAB5C-9A71-49BA-8C0A-7462A22D5F12Q24815767-91CD84EC-4F20-4500-B62A-53675F1253B5Q26751442-AC583190-B94B-4352-A500-065DDB311903Q26775796-E3DA8B73-E190-48B3-8CBE-C1B4F8EDF764Q26782931-7B4AC68A-D586-493A-B82B-F199D5D879AAQ26799395-AA9B4D6A-7FBB-40E0-8066-BC8B7D1BEE0BQ26828351-BAD65CE3-4C47-40DD-80F3-B2EA5DCF79E7Q26995027-E1157DC6-CC51-4057-80B6-8B8741779660Q27002491-6334A18F-5399-4865-979E-2A0410AFF8DDQ28165320-3CFC7D60-78C6-43D3-A72E-99378D57343DQ28198905-EEB164AD-EB35-42AD-A0B7-1B84B0D579EEQ28199912-46E9260B-EA27-4D1A-8235-703E91DF48C2Q28301431-56B5E84D-C345-4EF2-8593-BED9217EC602Q28368116-C01B14F3-35BD-4DDC-B609-96EEEB0D0541Q28379375-D015081E-A837-4391-9A29-BDC37D3A61A0Q30407109-2A5C5B12-0161-4D1A-ADF8-2A81093CE4D1Q30438893-55E376AA-A078-47F7-B30D-801ECC2F1A0AQ30472078-BE2DD79A-1060-43D0-A9B1-22DADF799D03Q30490718-8B06BBE2-0A23-4292-8D54-026B7937F0F1Q30497774-168EDC06-DCF2-4200-85A9-6070956D132EQ30525071-222E015C-2FDC-48AE-8CD5-89F452163975Q30710756-81F4F677-5984-460C-A9D6-904E550AD02CQ31042575-FCCFD834-FA6F-4241-B22F-2F04F52C0214
P2860
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Heparin-induced thrombocytopen ...... rin or unfractionated heparin.
@ast
Heparin-induced thrombocytopen ...... rin or unfractionated heparin.
@en
type
label
Heparin-induced thrombocytopen ...... rin or unfractionated heparin.
@ast
Heparin-induced thrombocytopen ...... rin or unfractionated heparin.
@en
prefLabel
Heparin-induced thrombocytopen ...... rin or unfractionated heparin.
@ast
Heparin-induced thrombocytopen ...... rin or unfractionated heparin.
@en
P2093
P1476
Heparin-induced thrombocytopen ...... rin or unfractionated heparin.
@en
P2093
P304
P356
10.1056/NEJM199505183322003
P407
P577
1995-05-01T00:00:00Z